查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529630

电池起始材料市场规模、份额、趋势分析报告：按产品、按等级、按最终用途、按地区、细分市场预测，2024-2030 年

Cellular Starting Materials Market Size, Share & Trends Analysis Report By Product (Leukopaks, Cells & Tissues), By Grade (GMP, Research-use), By End U-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

电池起始材料市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球电池起始材料市场规模将达到48.4亿美元，预计2024年至2030年复合年增长率为22.74%。

癌症、糖尿病和自体免疫疾病等慢性疾病的盛行率不断上升，投资不断增加，对细胞和基因疗法的需求不断增加，以及技术创新预计将在预测期内加强细胞原材料市场。

细胞起始材料在支持细胞和基因疗法的发展中发挥重要作用。这些对于自体和同种异体细胞治疗都是必不可少的。随着细胞治疗领域的不断快速扩展，对高品质人类细胞起始材料的需求不断增加。基于细胞的疗法正在针对多种疾病进行研究，包括癌症、神经退化性疾病和自体免疫疾病，增加了对不同类型起始材料的需求。此外，生物加工技术、细胞培养技术和品管措施的不断进步正在提高细胞原料製造的效率和扩充性，使公司能够提高这些材料的生产效率和可扩展性，同时保持产品品质和一致性。因应增加的需求。

COVID-19 大流行对市场产生了重大影响，供应链和製造流程中断，导致供不应求和製造计划延迟。对于自体细胞疗法，患者来源的细胞被用作起始材料，因此大流行延长了患者收集期。然而，这场大流行凸显了细胞疗法的重要性，导致该领域的投资增加，并加速了一些治疗方法的监管核准。

然而，与细胞治疗相关的严格法规对细胞起始材料市场构成了重大挑战。这些法规增加了细胞和基因治疗产品的製造成本以及获取起始材料的成本。世界各地对于细胞治疗的细胞起始材料的收集、加工和使用都有具体的规定。符合 21 CFR 1271.10(a) 中概述的具体标准的细胞治疗产品仅作为美国细胞、组织或细胞/组织衍生产品 (HCT/Ps) 根据《公共卫生服务法》第 361 条进行监管。

电池起始材料市场报告亮点

  • 2023年， 隐色将以70.80%的市场占有率占据该产品领域的主导地位。
  • 到 2023 年，GMP 将在该等级细分市场中占据主导地位，按收益计算占据最大的市场占有率，预计在预测期内将以 22.78% 的复合年增长率增长最高。
  • 製药和生物技术公司在最终用途市场占据主导地位，2023 年所占份额最大，为 51.04%。这是由于在研发方面进行了大量投资，将新的治疗方法推向市场，以及使用细胞起始材料作为製造过程中的关键组成部分。
  • 从最终用途来看，由于先进研究和製造技术投资的增加，CMO 和 CRO 领域预计将以最快的复合年增长率成长。
  • 由于研发活动投资增加、细胞疗法需求增加以及先进的医疗基础设施等因素，北美地区以 43.49% 的份额主导细胞起始材料市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 细胞起始材料市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
  • 电池原物料市场分析工具

第四章 电池原料市场：依产品分类的估算与趋势分析

  • 细分仪表板
  • 全球电池原料市场分产品波动分析
  • 2018-2030年全球电池原料市场规模及趋势分析（分产品）
  • 隐色包
  • 细胞和组织

第五章 电池原料市场：依等级估算及趋势分析

  • 细分仪表板
  • 全球电池原料市场依等级变化分析
  • 2018-2030年全球电池原料市场规模及趋势分析（依等级）
  • GMP
  • 研究

第六章 电池原料市场：依最终用途分类的估算与趋势分析

  • 细分仪表板
  • 全球电池原料市场最终用途的波动分析
  • 2018-2030 年全球蜂窝原料市场规模与趋势分析（依最终用途）
  • 製药和生物技术公司
  • 首席行销长和首席研究官
  • 学术研究所

第七章 电池原料市场：区域估算与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • AllCells
    • Charles River Laboratories
    • BioIVT
    • NMDP BioTherapies
    • CGT GLOBAL
    • Excellos
    • Anthony Nolan
    • STEMCELL Technologies
    • HumanCells Bio
    • AcceGen
Product Code: GVR-4-68040-323-4

Cellular Starting Materials Market Growth & Trends:

The global cellular starting materials market size is anticipated to reach USD 4.84 billion by 2030, growingand is anticipated to expand at a CAGR of 22.74% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, rising investments, growing demand for cell and gene-based therapies, and technological innovations are expected to enhance the cellular starting materials market over the forecast period.

Cellular starting materials play a crucial role in supporting the development of cell and gene therapies. They are essential for both autologous and allogeneic cell therapies. As the field of cell therapy continues to expand rapidly, the demand for high-quality human cellular starting material is increasingincreases. Cell-based treatments are being investigated for a variety of conditions, including oncology, neurodegenerative disorders, and autoimmune diseases, leading to increased demand for different types of starting materials. Moreover, ongoing advancements in bioprocessing technologies, cell culture techniques, and quality control measures have enhanced the efficiency and scalability of manufacturing cellular starting materials, enabling companies to meet the increasing demand for these materials while maintaining product quality and consistency.

The COVID-19 pandemic had a significant impact onsignificantly impacted the market, with disruptions in supply chains and manufacturing processes leading to shortages and delays in manufacturing timelines. In the case of autologous cell therapies, the pandemic has caused extended patient collection times as patient-derived cells are used as starting material. However, the pandemic also underscored the importance of cell-based therapies and led to increased investments in the sector and accelerated regulatory approvals for some treatments.

However, strict regulations related to cell therapies present a major challenge to the cellular starting materials market. These regulations increase the costs of manufacturing cell and gene therapy products and obtaining the starting material. Various regions around the worldworldwide have established specific regulations governing the collection, processing, and use of cellular starting material for cell therapies. Cellular therapy products meeting specific criteria outlined in 21 CFR 1271.10(a) are regulated solely as Human Cells, Tissues, and Cellular and & Tissue-Based Products (HCT/Ps) under Section 361 of the Public Health Service Act of the U.S.

Cellular Starting Materials Market Report Highlights:

  • Leukopaks dominated the product segment with a market share of 70.80% in 2023, as they are essential cellular starting materials for cell-based therapies.
  • In 2023, GMP dominated the grade segment and held the largest market share in terms of revenue and is expected to grow at the highest CAGR of 22.78% over the forecast period.
  • Pharmaceutical and biotechnology companies dominated the end-use market with the largest share of 51.04% in 2023, driven by their significant investment in research and development to bring novel treatments to market, leveraging cellular starting materials as key components in their manufacturing processes.
  • Based on end use, tThe CMOs & CROs segment is anticipated to grow at the fastest CAGR due to their increasing adoption and investment in advanced research and manufacturing technologies.
  • The North American region dominated the cellular starting materials market with a share of 43.49% owing to factors such as increasing investments in R&D activities, rising demand for cell-based therapies, and advanced healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Grade Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Cellular Starting Materials Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for cell therapies
      • 3.2.1.2. Advancements in research and development for cell-based therapies
      • 3.2.1.3. Technological innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with the production and procurement of raw materials for cell therapies
      • 3.2.2.2. Stringent regulations associated with cell therapies
  • 3.3. Cellular Starting Materials Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cellular Starting Materials Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cellular Starting Materials Market Product Movement Analysis
  • 4.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
  • 4.4. Leukopaks
    • 4.4.1. Leukopaks market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Cells & Tissues
    • 4.5.1. Cells & tissues market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Cellular Starting Materials Market: Grade Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cellular Starting Materials Market Grade Movement Analysis
  • 5.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Grade, 2018 - 2030 (USD Million)
  • 5.4. GMP
    • 5.4.1. GMP market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Research-use
    • 5.5.1. Research-use market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Cellular Starting Materials Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cellular Starting Materials Market End Use Movement Analysis
  • 6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. CMOs & CROs
    • 6.5.1. CMOs & CROs market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & research institutes market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Cellular Starting Materials Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030 (2018 - 2030)
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Target disease prevalence
      • 7.4.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Target disease prevalence
      • 7.4.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Target disease prevalence
      • 7.4.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Target disease prevalence
      • 7.5.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Target disease prevalence
      • 7.5.3.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Target disease prevalence
      • 7.5.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Target disease prevalence
      • 7.5.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Target disease prevalence
      • 7.5.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Target disease prevalence
      • 7.5.7.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Target disease prevalence
      • 7.5.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Target disease prevalence
      • 7.5.9.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Target disease prevalence
      • 7.6.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Target disease prevalence
      • 7.6.3.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Target disease prevalence
      • 7.6.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Target disease prevalence
      • 7.6.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Target disease prevalence
      • 7.6.6.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Target disease prevalence
      • 7.7.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Target disease prevalence
      • 7.7.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Target disease prevalence
      • 7.8.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Target disease prevalence
      • 7.8.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Target disease prevalence
      • 7.8.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Target disease prevalence
      • 7.8.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. AllCells
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Charles River Laboratories
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BioIVT
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. NMDP BioTherapies
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. CGT GLOBAL
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Excellos
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Anthony Nolan
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. STEMCELL Technologies
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. HumanCells Bio
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. AcceGen
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cellular starting materials market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 5 Global cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 9 North America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 12 U.S. cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 15 Canada cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 18 Mexico cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 22 Europe cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 25 Germany cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 28 UK cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 30 France cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 31 France cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 34 Italy cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 37 Spain cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 40 Denmark cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 43 Sweden cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 46 Norway cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 52 China cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 53 China cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 56 Japan cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 58 India cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 59 India cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 62 South Korea cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 65 Australia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 68 Thailand cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 72 Latin America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 75 Brazil cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 78 Argentina cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 82 MEA cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 85 South Africa cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 91 UAE cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 94 Kuwait cellular starting materials market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cellular Starting Materials market: Market outlook
  • Fig. 5 Cellular Starting Materials market: Segment outlook
  • Fig. 6 Cellular Starting Materials market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cellular starting materials market driver impact
  • Fig. 9 Cellular starting materials market restraint impact
  • Fig. 10 Cellular starting materials market: Product outlook and key takeaways
  • Fig. 11 Cellular starting materials market: Product movement analysis
  • Fig. 12 Leukopaks market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Cells & tissues market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Cellular starting materials market: Grade outlook and key takeaways
  • Fig. 15 Cellular starting materials market: Grade movement analysis
  • Fig. 16 GMP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Research-use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Cellular starting materials market: End use outlook and key takeaways
  • Fig. 19 Cellular starting materials market: End use movement analysis
  • Fig. 20 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 CMOs & CROs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 22 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global cellular starting materials market: Regional outlook and key takeaways
  • Fig. 24 Global cellular starting materials market: Regional movement analysis
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Key country dynamics
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Target Disease Prevalence
  • Fig. 29 Key country dynamics
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Target Disease Prevalence
  • Fig. 32 Key country dynamics
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Target Disease Prevalence
  • Fig. 35 Key country dynamics
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Target Disease Prevalence
  • Fig. 40 Key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Target Disease Prevalence
  • Fig. 43 Key country dynamics
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Target Disease Prevalence
  • Fig. 46 Key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Target Disease Prevalence
  • Fig. 49 Key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Target Disease Prevalence
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Target Disease Prevalence
  • Fig. 55 Key country dynamics
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Target Disease Prevalence
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Target Disease Prevalence
  • Fig. 61 Key country dynamics
  • Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Target Disease Prevalence
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Target Disease Prevalence
  • Fig. 69 Key country dynamics
  • Fig. 70 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Target Disease Prevalence
  • Fig. 72 Key country dynamics
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Target Disease Prevalence
  • Fig. 75 Key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Target Disease Prevalence
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Target Disease Prevalence
  • Fig. 81 Key country dynamics
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Target Disease Prevalence
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Target Disease Prevalence
  • Fig. 89 Key country dynamics
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Target Disease Prevalence
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Target Disease Prevalence
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Target Disease Prevalence
  • Fig. 100 Key country dynamics
  • Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Target Disease Prevalence
  • Fig. 103 Key country dynamics